| Interactions between Microbiome and DME (MICBIO)
|
| Bacteria: Actinobacteria |
| Bifidobacterium adolescentis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bifidobacterium adolescentis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bifidobacterium adolescentis co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bifidobacterium adolescentis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Bifidobacterium breve (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bifidobacterium breve co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bifidobacterium breve co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bifidobacterium breve co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bifidobacterium breve co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Bifidobacterium longum (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bifidobacterium longum co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [6] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bifidobacterium longum co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bifidobacterium longum co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Bifidobacterium ruminatum (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bifidobacterium ruminatum co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bifidobacterium ruminatum co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bifidobacterium ruminatum co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bifidobacterium ruminatum co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Collinsella aerofaciens (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Pitavastatin calcium |
Click to Show/Hide the Detail |
| Drug ID |
DR1306
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Collinsella aerofaciens co-metabolize the drug Pitavastatin calcium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Zidovudine |
Click to Show/Hide the Detail |
| Drug ID |
DR1729
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Collinsella aerofaciens co-metabolize the drug Zidovudine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Collinsella intestinalis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Collinsella intestinalis co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Collinsella intestinalis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Collinsella intestinalis co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Eggerthella lenta (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 6 Drugs Metabolized
|
| Eszopiclone |
Click to Show/Hide the Detail |
| Drug ID |
DR0652
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Eggerthella lenta co-metabolize the drug Eszopiclone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Eggerthella lenta co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Eggerthella lenta co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Eggerthella lenta co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Paclitaxel |
Click to Show/Hide the Detail |
| Drug ID |
DR1227
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Eggerthella lenta co-metabolize the drug Paclitaxel, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
| Sulfinpyrazone |
Click to Show/Hide the Detail |
| Drug ID |
DR1515
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Eggerthella lenta co-metabolize the drug Sulfinpyrazone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Streptomyces avermitilis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Diclofenac sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR0488
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Streptomyces avermitilis co-metabolize the drug Diclofenac sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [13], [14] |
| Testosterone cypionate |
Click to Show/Hide the Detail |
| Drug ID |
DR1564
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Streptomyces avermitilis co-metabolize the drug Testosterone cypionate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[15], [16], [13] |
| Bacteria: Bacteroidetes |
| Alistipes indistinctus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 5 Drugs Metabolized
|
| Cyclophosphamide |
Click to Show/Hide the Detail |
| Drug ID |
DR0391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Alistipes indistinctus co-metabolize the drug Cyclophosphamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[17], [2] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Alistipes indistinctus co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[18], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Alistipes indistinctus co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Alistipes indistinctus co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Alistipes indistinctus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Bacteroides caccae (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides caccae co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Bacteroides cellulosilyticus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides cellulosilyticus co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides cellulosilyticus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides cellulosilyticus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Bacteroides coprophilus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 6 Drugs Metabolized
|
| Eszopiclone |
Click to Show/Hide the Detail |
| Drug ID |
DR0652
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides coprophilus co-metabolize the drug Eszopiclone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides coprophilus co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides coprophilus co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Naloxone |
Click to Show/Hide the Detail |
| Drug ID |
DR1127
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides coprophilus co-metabolize the drug Naloxone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[20], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides coprophilus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides coprophilus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Bacteroides dorei (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 12 Drugs Metabolized
|
| Diclofenac sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR0488
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) metabolizes the drug Diclofenac sodium, and Bacteroides dorei further metabolizes its metabolite (Diclofenac glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[12], [21] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides dorei co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[18], [2] |
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides dorei co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Ketorolac |
Click to Show/Hide the Detail |
| Drug ID |
DR0908
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides dorei co-metabolize the drug Ketorolac, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides dorei co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [2] |
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides dorei co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides dorei co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides dorei co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides dorei co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Phenytoin |
Click to Show/Hide the Detail |
| Drug ID |
DR1282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides dorei co-metabolize the drug Phenytoin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Repaglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1404
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides dorei co-metabolize the drug Repaglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides dorei co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Bacteroides eggerthii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides eggerthii co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides eggerthii co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides eggerthii co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Bacteroides finegoldii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides finegoldii co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Bacteroides fragilis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 14 Drugs Metabolized
|
| Cyclophosphamide |
Click to Show/Hide the Detail |
| Drug ID |
DR0391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides fragilis co-metabolize the drug Cyclophosphamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[17], [2] |
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides fragilis co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Ketorolac |
Click to Show/Hide the Detail |
| Drug ID |
DR0908
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides fragilis co-metabolize the drug Ketorolac, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides fragilis co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [2] |
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides fragilis co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides fragilis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides fragilis co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Naloxone |
Click to Show/Hide the Detail |
| Drug ID |
DR1127
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides fragilis co-metabolize the drug Naloxone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[20], [2] |
| Naproxen |
Click to Show/Hide the Detail |
| Drug ID |
DR1130
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides fragilis co-metabolize the drug Naproxen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides fragilis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Paclitaxel |
Click to Show/Hide the Detail |
| Drug ID |
DR1227
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides fragilis co-metabolize the drug Paclitaxel, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
| Repaglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1404
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides fragilis co-metabolize the drug Repaglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Sulfinpyrazone |
Click to Show/Hide the Detail |
| Drug ID |
DR1515
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides fragilis co-metabolize the drug Sulfinpyrazone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Warfarin sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1717
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides fragilis co-metabolize the drug Warfarin sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Bacteroides intestinalis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides intestinalis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides intestinalis co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides intestinalis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides intestinalis co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Bacteroides oleiciplenus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides oleiciplenus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [25] |
| Bacteroides ovatus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides ovatus co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[18], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides ovatus co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Naloxone |
Click to Show/Hide the Detail |
| Drug ID |
DR1127
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides ovatus co-metabolize the drug Naloxone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[20], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides ovatus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Bacteroides sartorii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 13 Drugs Metabolized
|
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides sartorii co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[18], [2] |
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides sartorii co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Ketorolac |
Click to Show/Hide the Detail |
| Drug ID |
DR0908
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides sartorii co-metabolize the drug Ketorolac, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides sartorii co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [2] |
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides sartorii co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides sartorii co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides sartorii co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Naloxone |
Click to Show/Hide the Detail |
| Drug ID |
DR1127
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides sartorii co-metabolize the drug Naloxone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[20], [2] |
| Naproxen |
Click to Show/Hide the Detail |
| Drug ID |
DR1130
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides sartorii co-metabolize the drug Naproxen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides sartorii co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Paclitaxel |
Click to Show/Hide the Detail |
| Drug ID |
DR1227
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides sartorii co-metabolize the drug Paclitaxel, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
| Phenytoin |
Click to Show/Hide the Detail |
| Drug ID |
DR1282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides sartorii co-metabolize the drug Phenytoin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Repaglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1404
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides sartorii co-metabolize the drug Repaglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Bacteroides stercoris (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides stercoris co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides stercoris co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides stercoris co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Bacteroides thetaiotaomicron (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 10 Drugs Metabolized
|
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides thetaiotaomicron co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[18], [2] |
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides thetaiotaomicron co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides thetaiotaomicron co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [6] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides thetaiotaomicron co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Naloxone |
Click to Show/Hide the Detail |
| Drug ID |
DR1127
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides thetaiotaomicron co-metabolize the drug Naloxone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[20], [2] |
| Naproxen |
Click to Show/Hide the Detail |
| Drug ID |
DR1130
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides thetaiotaomicron co-metabolize the drug Naproxen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides thetaiotaomicron co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Paclitaxel |
Click to Show/Hide the Detail |
| Drug ID |
DR1227
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides thetaiotaomicron co-metabolize the drug Paclitaxel, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
| Repaglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1404
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides thetaiotaomicron co-metabolize the drug Repaglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Sulfinpyrazone |
Click to Show/Hide the Detail |
| Drug ID |
DR1515
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides thetaiotaomicron co-metabolize the drug Sulfinpyrazone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Bacteroides uniformis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Cefaloridine |
Click to Show/Hide the Detail |
| Drug ID |
DR0285
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides uniformis co-metabolize the drug Cefaloridine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[26], [27] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides uniformis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides uniformis co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides uniformis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Bacteroides vulgatus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 14 Drugs Metabolized
|
| Imatinib mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0858
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides vulgatus co-metabolize the drug Imatinib mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[15], [2] |
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides vulgatus co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Ketorolac |
Click to Show/Hide the Detail |
| Drug ID |
DR0908
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides vulgatus co-metabolize the drug Ketorolac, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides vulgatus co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [2] |
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides vulgatus co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides vulgatus co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides vulgatus co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Naproxen |
Click to Show/Hide the Detail |
| Drug ID |
DR1130
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides vulgatus co-metabolize the drug Naproxen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides vulgatus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Phenytoin |
Click to Show/Hide the Detail |
| Drug ID |
DR1282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides vulgatus co-metabolize the drug Phenytoin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Repaglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1404
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides vulgatus co-metabolize the drug Repaglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides vulgatus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Verapamil hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1681
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides vulgatus co-metabolize the drug Verapamil hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
| Warfarin sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1717
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides vulgatus co-metabolize the drug Warfarin sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Bacteroides xylanisolvens (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 13 Drugs Metabolized
|
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides xylanisolvens co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[18], [2] |
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides xylanisolvens co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Ketorolac |
Click to Show/Hide the Detail |
| Drug ID |
DR0908
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides xylanisolvens co-metabolize the drug Ketorolac, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides xylanisolvens co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [2] |
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides xylanisolvens co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides xylanisolvens co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides xylanisolvens co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Naproxen |
Click to Show/Hide the Detail |
| Drug ID |
DR1130
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides xylanisolvens co-metabolize the drug Naproxen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides xylanisolvens co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Paclitaxel |
Click to Show/Hide the Detail |
| Drug ID |
DR1227
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides xylanisolvens co-metabolize the drug Paclitaxel, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
| Phenytoin |
Click to Show/Hide the Detail |
| Drug ID |
DR1282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides xylanisolvens co-metabolize the drug Phenytoin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Repaglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1404
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides xylanisolvens co-metabolize the drug Repaglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Sulfinpyrazone |
Click to Show/Hide the Detail |
| Drug ID |
DR1515
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides xylanisolvens co-metabolize the drug Sulfinpyrazone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Odoribacter splanchnicus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 11 Drugs Metabolized
|
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Odoribacter splanchnicus co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Odoribacter splanchnicus co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [2] |
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Odoribacter splanchnicus co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Odoribacter splanchnicus co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Odoribacter splanchnicus co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Naproxen |
Click to Show/Hide the Detail |
| Drug ID |
DR1130
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Odoribacter splanchnicus co-metabolize the drug Naproxen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Odoribacter splanchnicus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Paclitaxel |
Click to Show/Hide the Detail |
| Drug ID |
DR1227
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Odoribacter splanchnicus co-metabolize the drug Paclitaxel, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
| Repaglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1404
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Odoribacter splanchnicus co-metabolize the drug Repaglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Sulfinpyrazone |
Click to Show/Hide the Detail |
| Drug ID |
DR1515
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Odoribacter splanchnicus co-metabolize the drug Sulfinpyrazone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Odoribacter splanchnicus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Parabacteroides distasonis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 7 Drugs Metabolized
|
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Parabacteroides distasonis co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[18], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Parabacteroides distasonis co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [2] |
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Parabacteroides distasonis co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Parabacteroides distasonis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Parabacteroides distasonis co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Naproxen |
Click to Show/Hide the Detail |
| Drug ID |
DR1130
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Parabacteroides distasonis co-metabolize the drug Naproxen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Phenytoin |
Click to Show/Hide the Detail |
| Drug ID |
DR1282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Parabacteroides distasonis co-metabolize the drug Phenytoin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Parabacteroides johnsonii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 8 Drugs Metabolized
|
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Parabacteroides johnsonii co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[18], [2] |
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Parabacteroides johnsonii co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Parabacteroides johnsonii co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Parabacteroides johnsonii co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Parabacteroides johnsonii co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Parabacteroides johnsonii co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Sulfinpyrazone |
Click to Show/Hide the Detail |
| Drug ID |
DR1515
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Parabacteroides johnsonii co-metabolize the drug Sulfinpyrazone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Parabacteroides johnsonii co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Parabacteroides merdae (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 5 Drugs Metabolized
|
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Parabacteroides merdae co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Parabacteroides merdae co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Parabacteroides merdae co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Parabacteroides merdae co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Parabacteroides merdae co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Prevotella copri (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 5 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Prevotella copri co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Prevotella copri co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Naloxone |
Click to Show/Hide the Detail |
| Drug ID |
DR1127
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Prevotella copri co-metabolize the drug Naloxone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[20], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Prevotella copri co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Prevotella copri co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Bacteria: Firmicutes |
| Anaerobutyricum hallii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Eszopiclone |
Click to Show/Hide the Detail |
| Drug ID |
DR0652
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Anaerobutyricum hallii co-metabolize the drug Eszopiclone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Anaerobutyricum hallii co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Anaerobutyricum hallii co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Anaerobutyricum hallii co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Anaerococcus hydrogenalis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 5 Drugs Metabolized
|
| Eszopiclone |
Click to Show/Hide the Detail |
| Drug ID |
DR0652
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Anaerococcus hydrogenalis co-metabolize the drug Eszopiclone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Anaerococcus hydrogenalis co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Anaerococcus hydrogenalis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Anaerococcus hydrogenalis co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Zidovudine |
Click to Show/Hide the Detail |
| Drug ID |
DR1729
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Anaerococcus hydrogenalis co-metabolize the drug Zidovudine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Anaerostipes hadrus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Imatinib mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0858
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Anaerostipes hadrus co-metabolize the drug Imatinib mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[15], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Anaerostipes hadrus co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Anaerostipes hadrus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Anaerotruncus colihominis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Anaerotruncus colihominis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Anaerotruncus colihominis co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Bacillus megaterium (firmicutes) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Amodiaquine |
Click to Show/Hide the Detail |
| Drug ID |
DR0102
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacillus megaterium co-metabolize the drug Amodiaquine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [30] |
| Diclofenac sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR0488
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacillus megaterium co-metabolize the drug Diclofenac sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [31] |
| Mefenamic acid |
Click to Show/Hide the Detail |
| Drug ID |
DR1014
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacillus megaterium co-metabolize the drug Mefenamic acid, which can collectively affect efficacy, safety or bioavailability of this drug. |
[15], [31] |
| Testosterone cypionate |
Click to Show/Hide the Detail |
| Drug ID |
DR1564
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacillus megaterium co-metabolize the drug Testosterone cypionate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[15], [32], [33] |
| Bacteroides pectinophilus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides pectinophilus co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides pectinophilus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Bacteroides pectinophilus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Blautia hansenii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 8 Drugs Metabolized
|
| Anastrozole |
Click to Show/Hide the Detail |
| Drug ID |
DR0113
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Blautia hansenii co-metabolize the drug Anastrozole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[34], [2] |
| Cyclophosphamide |
Click to Show/Hide the Detail |
| Drug ID |
DR0391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Blautia hansenii co-metabolize the drug Cyclophosphamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[17], [2] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Blautia hansenii co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[18], [2] |
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Blautia hansenii co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Blautia hansenii co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Blautia hansenii co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Blautia hansenii co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Blautia hansenii co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Blautia luti (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Blautia luti co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Blautia luti co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Clostridioides difficile (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Clostridioides difficile co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Clostridioides difficile co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Clostridium botulinum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 9 Drugs Metabolized
|
| Anastrozole |
Click to Show/Hide the Detail |
| Drug ID |
DR0113
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Clostridium botulinum co-metabolize the drug Anastrozole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[34], [2] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Clostridium botulinum co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[18], [2] |
| Eszopiclone |
Click to Show/Hide the Detail |
| Drug ID |
DR0652
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Clostridium botulinum co-metabolize the drug Eszopiclone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Ketorolac |
Click to Show/Hide the Detail |
| Drug ID |
DR0908
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Clostridium botulinum co-metabolize the drug Ketorolac, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Clostridium botulinum co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Clostridium botulinum co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Clostridium botulinum co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Clostridium botulinum co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Clostridium botulinum co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Clostridium perfringens (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Clostridium perfringens co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [6] |
| Clostridium scindens (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Clostridium scindens co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Clostridium scindens co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Clostridium scindens co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Clostridium spiroforme (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Clostridium spiroforme co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Clostridium spiroforme co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Clostridium spiroforme co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Clostridium sporogenes (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Celecoxib |
Click to Show/Hide the Detail |
| Drug ID |
DR0286
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Clostridium sporogenes co-metabolize the drug Celecoxib, which can collectively affect efficacy, safety or bioavailability of this drug. |
[35], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Clostridium sporogenes co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Clostridium sporogenes co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Clostridium symbiosum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Eszopiclone |
Click to Show/Hide the Detail |
| Drug ID |
DR0652
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Clostridium symbiosum co-metabolize the drug Eszopiclone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Clostridium symbiosum co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Clostridium symbiosum co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Coprococcus comes (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Coprococcus comes co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Coprococcus comes co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Coprococcus comes co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Dorea formicigenerans (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Dorea formicigenerans co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Dorea formicigenerans co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Dorea formicigenerans co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Enterocloster asparagiformis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Enterocloster asparagiformis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Enterocloster asparagiformis co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Enterocloster asparagiformis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Enterocloster bolteae (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Enterocloster bolteae co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Enterocloster bolteae co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Enterocloster bolteae co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Enterococcus faecalis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Enterococcus faecalis co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Enterococcus faecalis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Erysipelatoclostridium ramosum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Erysipelatoclostridium ramosum co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Erysipelatoclostridium ramosum co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Eubacterium limosum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Eubacterium limosum co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [6] |
| Eubacterium rectale (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Eszopiclone |
Click to Show/Hide the Detail |
| Drug ID |
DR0652
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Eubacterium rectale co-metabolize the drug Eszopiclone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Eubacterium rectale co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Eubacterium rectale co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Eubacterium ventriosum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Eubacterium ventriosum co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Eubacterium ventriosum co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Faecalibacterium prausnitzii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Diclofenac sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR0488
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) metabolizes the drug Diclofenac sodium, and Faecalibacterium prausnitzii further metabolizes its metabolite (Diclofenac glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[12], [21] |
| Holdemanella biformis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 6 Drugs Metabolized
|
| Celecoxib |
Click to Show/Hide the Detail |
| Drug ID |
DR0286
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Holdemanella biformis co-metabolize the drug Celecoxib, which can collectively affect efficacy, safety or bioavailability of this drug. |
[35], [2] |
| Cyclophosphamide |
Click to Show/Hide the Detail |
| Drug ID |
DR0391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Holdemanella biformis co-metabolize the drug Cyclophosphamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[17], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Holdemanella biformis co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Holdemanella biformis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Holdemanella biformis co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Holdemanella biformis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Hungatella hathewayi (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Hungatella hathewayi co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Hungatella hathewayi co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Hungatella hathewayi co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Lactobacillus johnsonii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Tegafur |
Click to Show/Hide the Detail |
| Drug ID |
DR1539
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Lactobacillus johnsonii co-metabolize the drug Tegafur, which can collectively affect efficacy, safety or bioavailability of this drug. |
[36], [37] |
| Lactobacillus reuteri (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Lactobacillus reuteri co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Lactobacillus reuteri co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Lactobacillus rhamnosus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Diclofenac sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR0488
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) metabolizes the drug Diclofenac sodium, and Lactobacillus rhamnosus further metabolizes its metabolite (Diclofenac glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[12], [21] |
| Marvinbryantia formatexigens (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Eszopiclone |
Click to Show/Hide the Detail |
| Drug ID |
DR0652
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Marvinbryantia formatexigens co-metabolize the drug Eszopiclone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Marvinbryantia formatexigens co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Marvinbryantia formatexigens co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Roseburia intestinalis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Roseburia intestinalis co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Roseburia intestinalis co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Roseburia intestinalis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Roseburia intestinalis co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Ruminococcus gnavus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Diclofenac sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR0488
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) metabolizes the drug Diclofenac sodium, and Ruminococcus gnavus further metabolizes its metabolite (Diclofenac glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[12], [21] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Ruminococcus gnavus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Ruminococcus gnavus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Ruminococcus lactaris (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Eszopiclone |
Click to Show/Hide the Detail |
| Drug ID |
DR0652
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Ruminococcus lactaris co-metabolize the drug Eszopiclone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Ruminococcus lactaris co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Ruminococcus lactaris co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Ruminococcus torques (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Ruminococcus torques co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Ruminococcus torques co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Subdoligranulum variabile (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Subdoligranulum variabile co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Subdoligranulum variabile co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Bacteria: Fusobacteria |
| Fusobacterium varium (fusobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Fusobacterium varium co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [6] |
| Bacteria: Lentisphaerae |
| Victivallis vadensis (PVC bacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Victivallis vadensis co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[18], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Victivallis vadensis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Victivallis vadensis co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Victivallis vadensis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Bacteria: Proteobacteria |
| Burkholderia multivorans (beta-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Cefaloridine |
Click to Show/Hide the Detail |
| Drug ID |
DR0285
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Burkholderia multivorans co-metabolize the drug Cefaloridine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[26], [38] |
| Edwardsiella tarda (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Edwardsiella tarda co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Edwardsiella tarda co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Edwardsiella tarda co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Enterobacter cancerogenus (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Enterobacter cancerogenus co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Enterobacter cancerogenus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Enterobacter cancerogenus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Escherichia coli (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 6 Drugs Metabolized
|
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Escherichia coli co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Escherichia coli co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [39] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Escherichia coli co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Escherichia coli co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Paclitaxel |
Click to Show/Hide the Detail |
| Drug ID |
DR1227
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Escherichia coli co-metabolize the drug Paclitaxel, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
| Sulfinpyrazone |
Click to Show/Hide the Detail |
| Drug ID |
DR1515
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Escherichia coli co-metabolize the drug Sulfinpyrazone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Proteus penneri (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Proteus penneri co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Proteus penneri co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Proteus penneri co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Providencia alcalifaciens (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Providencia alcalifaciens co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Providencia alcalifaciens co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Providencia rettgeri (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Providencia rettgeri co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Providencia rettgeri co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Providencia rettgeri co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Providencia stuartii (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Providencia stuartii co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Providencia stuartii co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Providencia stuartii co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Pseudomonas putida (gamma-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Nicotine |
Click to Show/Hide the Detail |
| Drug ID |
DR1148
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Pseudomonas putida co-metabolize the drug Nicotine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[40], [41] |
| Salmonella enterica (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Salmonella enterica co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Salmonella enterica co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Shewanella oneidensis (gamma-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Sulfamethoxazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1511
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Shewanella oneidensis co-metabolize the drug Sulfamethoxazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[42], [43], [44] |
| Sphingomonas colocasiae (alpha-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Ibuprofen |
Click to Show/Hide the Detail |
| Drug ID |
DR0844
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Sphingomonas colocasiae co-metabolize the drug Ibuprofen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[45], [46] |
| Bacteria: Synergistetes |
| Synergistetes bacterium (synergistetes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Sulfamethoxazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1511
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Synergistetes bacterium co-metabolize the drug Sulfamethoxazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[42], [47], [48] |
| Bacteria: Verrucomicrobia |
| Akkermansia muciniphila (verrucomicrobiae) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Akkermansia muciniphila co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2C8 (CYP2C8) and Akkermansia muciniphila co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
|
|
|
|
|
|